Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00896740 · ClinicalTrials.gov registry record
Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 90
- Enrollment target
NCT00896740: Clinical Trial study, sponsored by OHSU Knight Cancer Institute.
NCT00896740 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00896740 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 90 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of bone marrow from patients with Fanconi anemia and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to Fanconi anemia. PURPOSE: This laboratory study is evaluating gene function in bone marrow cells from patients with Fanconi anemia and from healthy participants.
Interventions
- GENETIC microarray analysis
- PROCEDURE biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-03 |
| Est. Completion | 2007-09 |
Why NCT00896740 stopped before completion
NCT00896740 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00896740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00896740 about?
NCT00896740 is a clinical study titled "Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants". RATIONALE: Studying samples of bone marrow from patients with Fanconi anemia and from healthy participants in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to Fanconi anemia. PURPOSE: This laboratory study is evaluating gene function in b...
What is the current status of trial NCT00896740?
This trial is currently terminated. The enrollment target is 90 participants. The study started on 2002-03. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00896740?
The interventions under investigation include: microarray analysis (GENETIC), biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00896740?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia